114 related articles for article (PubMed ID: 28063265)
1. PEGylation potentiates hepatoma cell targeted liposome-mediated in vitro gene delivery via the asialoglycoprotein receptor.
Mkhwanazi NK; de Koning CB; van Otterlo WAL; Ariatti M; Singh M
Z Naturforsch C J Biosci; 2017 Jul; 72(7-8):293-301. PubMed ID: 28063265
[TBL] [Abstract][Full Text] [Related]
2. PEGylated galactosylated cationic liposomes for hepatocytic gene delivery.
Naicker K; Ariatti M; Singh M
Colloids Surf B Biointerfaces; 2014 Oct; 122():482-490. PubMed ID: 25096720
[TBL] [Abstract][Full Text] [Related]
3. Biotin-directed assembly of targeted modular lipoplexes and their transfection of human hepatoma cells in vitro.
Singh A; Ariatti M; Singh M; Hawtrey A; Naidoo R
Drug Deliv; 2010 Aug; 17(6):426-33. PubMed ID: 20469969
[TBL] [Abstract][Full Text] [Related]
4. Glycosylated liposomes with proton sponge capacity: novel hepatocyte- specific gene carriers.
Habib S; Singh M; Ariatti M
Curr Drug Deliv; 2013 Dec; 10(6):685-95. PubMed ID: 23859358
[TBL] [Abstract][Full Text] [Related]
5. Stealth lipoplex decorated with triazole-tethered galactosyl moieties: a strong hepatotropic gene vector.
Govender D; Islam RU; De Koning CB; van Otterlo WA; Arbuthnot P; Ariatti M; Singh M
Biotechnol Lett; 2015 Mar; 37(3):567-75. PubMed ID: 25432417
[TBL] [Abstract][Full Text] [Related]
6. Novel neo glycolipid: formulation into pegylated cationic liposomes and targeting of DNA lipoplexes to the hepatocyte-derived cell line HepG2.
Narainpersad N; Singh M; Ariatti M
Nucleosides Nucleotides Nucleic Acids; 2012; 31(3):206-23. PubMed ID: 22356236
[TBL] [Abstract][Full Text] [Related]
7. Novel targeted liposomes deliver sirna to hepatocellular carcinoma cells in vitro.
Dorasamy S; Narainpersad N; Singh M; Ariatti M
Chem Biol Drug Des; 2012 Nov; 80(5):647-56. PubMed ID: 22783887
[TBL] [Abstract][Full Text] [Related]
8. Spacer Length: A Determining Factor in the Design of Galactosyl Ligands for Hepatoma Cell-Specific Liposomal Gene Delivery.
Mbatha L; Chakravorty S; de Koning CB; van Otterlo WA; Arbuthnot P; Ariatti M; Singh M
Curr Drug Deliv; 2016; 13(6):935-45. PubMed ID: 26906564
[TBL] [Abstract][Full Text] [Related]
9. A novel lactoferrin-modified stealth liposome for hepatoma-delivery of triiodothyronine.
Pireddu R; Pibiri M; Valenti D; Sinico C; Fadda AM; Simbula G; Lai F
Int J Pharm; 2018 Feb; 537(1-2):257-267. PubMed ID: 29294323
[TBL] [Abstract][Full Text] [Related]
10. Asialoglycoprotein receptor targeted micelles containing carborane clusters for effective boron neutron capture therapy of hepatocellular carcinoma.
Zhang T; Li G; Li S; Wang Z; He D; Wang Y; Zhang J; Li J; Bai Z; Zhang Q; Liu B; Zhao Q; Liu Y; Zhang H
Colloids Surf B Biointerfaces; 2019 Oct; 182():110397. PubMed ID: 31357127
[TBL] [Abstract][Full Text] [Related]
11. Specific and efficient gene delivery mediated by an asialofetuin-associated nanosystem.
Farinha D; Pedroso de Lima MC; Faneca H
Int J Pharm; 2014 Oct; 473(1-2):366-74. PubMed ID: 25051113
[TBL] [Abstract][Full Text] [Related]
12. Design of cholesterol arabinogalactan anchored liposomes for asialoglycoprotein receptor mediated targeting to hepatocellular carcinoma: In silico modeling, in vitro and in vivo evaluation.
Pathak P; Dhawan V; Magarkar A; Danne R; Govindarajan S; Ghosh S; Steiniger F; Chaudhari P; Gopal V; Bunker A; Róg T; Fahr A; Nagarsenker M
Int J Pharm; 2016 Jul; 509(1-2):149-158. PubMed ID: 27231122
[TBL] [Abstract][Full Text] [Related]
13. [In vitro targeting effect of lactoferrin modified PEGylated liposomes for hepatoma cells].
Wei MY; Zou Q; Wu CB; Xu YH
Yao Xue Xue Bao; 2015 Oct; 50(10):1272-9. PubMed ID: 26837173
[TBL] [Abstract][Full Text] [Related]
14. Novel histidine-conjugated galactosylated cationic liposomes for efficient hepatocyte-selective gene transfer in human hepatoma HepG2 cells.
Shigeta K; Kawakami S; Higuchi Y; Okuda T; Yagi H; Yamashita F; Hashida M
J Control Release; 2007 Apr; 118(2):262-70. PubMed ID: 17267065
[TBL] [Abstract][Full Text] [Related]
15. Targeted gene delivery into HepG2 cells using complexes containing DNA, cationized asialoorosomucoid and activated cationic liposomes.
Singh M; Ariatti M
J Control Release; 2003 Oct; 92(3):383-94. PubMed ID: 14568419
[TBL] [Abstract][Full Text] [Related]
16. Effect of Poly(ethylene glycol) Spacer on Peptide-Decorated Hepatocellular Carcinoma-Targeted Lipoplexes In Vitro.
Govender J; Singh M; Ariatti M
J Nanosci Nanotechnol; 2015 Jun; 15(6):4734-42. PubMed ID: 26369105
[TBL] [Abstract][Full Text] [Related]
17. Increased gene delivery efficiency and specificity of a lipid-based nanosystem incorporating a glycolipid.
Magalhães M; Farinha D; Pedroso de Lima MC; Faneca H
Int J Nanomedicine; 2014; 9():4979-89. PubMed ID: 25368518
[TBL] [Abstract][Full Text] [Related]
18. Lactoferrin-modified PEGylated liposomes loaded with doxorubicin for targeting delivery to hepatocellular carcinoma.
Wei M; Guo X; Tu L; Zou Q; Li Q; Tang C; Chen B; Xu Y; Wu C
Int J Nanomedicine; 2015; 10():5123-37. PubMed ID: 26316745
[TBL] [Abstract][Full Text] [Related]
19. Asialoglycoprotein receptor-targeted liposomes loaded with a norcantharimide derivative for hepatocyte-selective targeting.
Liu X; Han M; Xu J; Geng S; Zhang Y; Ye X; Gou J; Yin T; He H; Tang X
Int J Pharm; 2017 Mar; 520(1-2):98-110. PubMed ID: 28167263
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of novel mono- and bivalent ASGP-R-targeted drug-conjugates.
Petrov RA; Maklakova SY; Ivanenkov YA; Petrov SA; Sergeeva OV; Yamansarov EY; Saltykova IV; Kireev II; Alieva IB; Deyneka EV; Sofronova AA; Aladinskaia AV; Trofimenko AV; Yamidanov RS; Kovalev SV; Kotelianski VE; Zatsepin TS; Beloglazkina EK; Majouga AG
Bioorg Med Chem Lett; 2018 Feb; 28(3):382-387. PubMed ID: 29269214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
